May 19, 2021 5:00pm EDT Sutro Biopharma Announces Additional Data for Dose-Escalation Phase 1 Study of STRO-002 to be Presented at ASCO 2021
May 07, 2021 7:00am EDT Sutro Biopharma Reports First Quarter 2021 Financial Results, Business Highlights and 2021 Anticipated Milestones
Apr 20, 2021 7:00am EDT Sutro Biopharma Promotes Trevor Hallam, Ph.D., to President of Research and Chief Scientific Officer
Apr 15, 2021 7:00am EDT Sutro Biopharma Earns Milestone Payment from Cytokine Derivatives Collaboration with Merck
Mar 22, 2021 7:00am EDT Sutro Biopharma Strengthens Leadership Through Management Promotions and Expansion of Clinical Advisory Board
Mar 18, 2021 7:00am EDT Sutro Biopharma Reports Full Year 2020 Financial Results and Provides Business Highlights and 2021 Anticipated Milestones
Feb 23, 2021 7:00am EST Sutro Biopharma to Participate in the Cowen 41st Annual Healthcare Conference
Jan 21, 2021 7:00am EST Sutro Biopharma Announces First Patient Dosed in the Dose-Expansion Study of STRO-002 in Patients with Ovarian Cancer
